The EU will announce the results of the AstraZeneca vaccine evaluation WHO: The benefits of vaccination exceed the risks
China News Service, April 7th. Comprehensive foreign media reported that due to reports of rare cases of cerebral thrombosis after vaccination with AstraZeneca in many European countries, there has been controversy over the safety of the vaccine. The European Medicines Agency will release the latest review results of the vaccine on the 7th or 8th. At the same time, a World Health Organization official said on the 6th that there is no evidence for the WHO to change its position that the benefits of AstraZeneca vaccine still outweigh the risks.